Alcon Inc (ALC)
85.57
+0.07
(+0.08%)
USD |
NYSE |
Nov 21, 16:00
85.53
-0.04
(-0.05%)
After-Hours: 20:00
Alcon Net Income (Quarterly): 263.00M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 263.00M |
June 30, 2024 | 223.00M |
March 31, 2024 | 248.00M |
December 31, 2023 | 427.00M |
September 30, 2023 | 204.00M |
June 30, 2023 | 169.00M |
March 31, 2023 | 174.00M |
December 31, 2022 | -97.00M |
September 30, 2022 | 116.00M |
June 30, 2022 | 148.00M |
March 31, 2022 | 168.00M |
December 31, 2021 | 139.00M |
September 30, 2021 | 2.00M |
Date | Value |
---|---|
June 30, 2021 | 151.00M |
March 31, 2021 | 84.00M |
December 31, 2020 | 95.00M |
September 30, 2020 | -147.00M |
June 30, 2020 | -422.00M |
March 31, 2020 | -57.00M |
December 31, 2019 | -91.00M |
September 30, 2019 | -66.00M |
June 30, 2019 | -390.00M |
March 31, 2019 | -109.00M |
December 31, 2018 | -73.00M |
September 30, 2018 | -207.00M |
June 30, 2018 | 15.00M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-422.00M
Minimum
Jun 2020
427.00M
Maximum
Dec 2023
89.85M
Average
143.50M
Median
Net Income (Quarterly) Benchmarks
AC Immune SA | 6.364M |
CRISPR Therapeutics AG | -85.94M |
Addex Therapeutics Ltd | 14.24M |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | -18.97M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 2.454B |
Total Expenses (Quarterly) | 2.122B |
EPS Diluted (Quarterly) | 0.53 |
Enterprise Value | 45.64B |
Gross Profit Margin (Quarterly) | 55.87% |
Profit Margin (Quarterly) | 10.72% |
Earnings Yield | 2.73% |
Operating Earnings Yield | 2.88% |
Normalized Earnings Yield | 2.735 |